A Study on Core Outcome Set of Traditional Chinese Medicine for Treatment of Bronchiectasis

Bronchiectasis (BE) is a heterogeneous inflammatory chronic disease of the airway caused by repeated suppurative infection caused by various etiologies, which leads to abnormal and permanent dilation of the bronchi and bronchioles. It is manifested as chronic cough and expectoration, which can be repeatedly infected and often accompanied by hemoptysis. Clinically, it includes two key stages of the disease: stable stage and acute exacerbation stage. In traditional Chinese medicine, it belongs to the categories of "cough", "lung carbuncle" and "hemoptysis". Now it has become the third most common chronic airway disease in the world after chronic obstructive pulmonary disease and bronchial asthma, which seriously affects the quality of life of patients. Conventional western medicine mostly uses anti-infection, anti-inflammatory and airway clearance techniques, but the long-term application of antibiotics and glucocorticoids caused drug resistance leads to a poor prognosis of the disease. TCM intervention in BE can improve the high secretion of airway mucus, delay the decline of lung function, and improve the quality of life. However, the outcome selection of existing TCM clinical trials is messy, the results of similar studies are heterogeneous, and there is a general risk of selective reporting bias. Therefore, it is very necessary and urgent to establish a Core outcome set (COS) on TCM for bronchiectasis.I will take the existing overarching bronchiectasis COS as default core outcomes(https://doi.org/10.1016/j.heliyon.2024.e34101)

Contributors

Principal investigator:
Yumeng Song, Liaoning University of Traditional Chinese Medicine,Shenyang,Liaoning,China

Other contributors:
Jiyu Zou,Ningzi Zang,Lijian Pang,Xiaodong Lv, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang,Liaoning,China

Further Study Information

Current Stage: Ongoing
Date: August 2026 - December 2028
Funding source(s): None


Health Area

Disease Category: Lungs & airways

Disease Name: Bronchiectasis

Target Population

Age Range: 0 - 100

Sex: Either

Nature of Intervention: Complementary and alternative medicine (CAM) therapy, Traditional Chinese Medicine

Stakeholders Involved

- Clinical experts
- Conference participants
- Consumers (patients)
- Researchers

Study Type

- COS for clinical trials or clinical research
- COS for practice

Method(s)

- Consensus conference
- Delphi process
- Interview
- Systematic review

(1) Systematic literature review
(2) Qualitative semi-structured interview
(3) Two rounds Delphi Survey
(4) Consensus conference

Linked Studies

    No related studies


Related Links

    No related links